Supernus Pharmaceuticals
SUPN
SUPN
245 hedge funds and large institutions have $1.67B invested in Supernus Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 85 increasing their positions, 89 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% less call options, than puts
Call options by funds: $766K | Put options by funds: $778K
4% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 89
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
245
Holding in Top 10
2
Calls
$766K
Puts
$778K
Top Buyers
| 1 | +$26.6M | |
| 2 | +$15.7M | |
| 3 | +$8.24M | |
| 4 |
BlackRock
New York
|
+$5.87M |
| 5 |
SIMG
Stephens Investment Management Group
Houston,
Texas
|
+$5.79M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$12.8M | |
| 3 | -$6.07M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$5.53M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.8M |